Noven Announces Annual Meeting Results

NOVEN ANNOUNCES ANNUAL MEETING RESULTS

Miami, FL, May 25, 2005 -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the results of its 2005 Annual Meeting of Stockholders. At the meeting, held May 24, 2005, stockholders elected the following persons to the Noven Board of Directors

	•	Sidney Braginsky – President & CEO, Atropos Technology Inc.;
	•	John G. Clarkson, M.D. – Professor & Senior Vice President for Medical Affairs & Dean, University of Miami School of Medicine;
	•	Donald A. Denkhaus – Chairman, TM Systems, LLC;
	•	Pedro P. Granadillo – Senior Vice President – Global Manufacturing & Human Resources (Retired), Eli Lilly & Company;
	•	Robert G. Savage – Worldwide Chairman, Pharmaceutical Group (Retired), Johnson & Johnson;
	•	Robert C. Strauss – President, Chief Executive Officer & Chairman, Noven Pharmaceuticals; and
	•	Wayne P. Yetter – Chief Executive Officer, Odyssey Pharmaceuticals, Inc.

Stockholders also ratified the appointment of Deloitte & Touche LLP as Noven’s independent registered public accounting firm for 2005. At the meeting, Robert Strauss made a presentation regarding Noven’s business and prospects, a replay of which is available at www.noven.com.

Noven Pharmaceuticals, Inc. is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products.

Contact:
Joseph C. Jones
Vice President – Corporate Affairs
Noven Pharmaceuticals, Inc.
(305) 253-1916

Back